fuz2021-02-25 08:26:23

Moderna says COVID vaccine tweaked for South African variant is ready for testing 

https://www.marketwatch.com/story/moderna-says-covid-vaccine-tweaked-for-south-african-variant-is-ready-for-testing-11614201495

People who have received two doses of Moderna’s original shot will be given the new one, and researchers will track its safety and efficacy.

.........

 

Pfizer also working on the third dose

https://www.nbcnews.com/news/amp/ncna1258775

Pfizer CEO Albert Bourla said the hope is that a third dose will boost the immune response even higher, offering better protection against variants.

"We believe that the third dose," Bourla said, "will raise the antibody response 10- to 20- fold."

The new study will monitor the safety and efficacy of a third dose in two age groups: those 18 to 55 and those 65 to 85. The participants come from a group of people who were among the first to receive the Pfizer-BioNTech vaccine: people who volunteered for Pfizer's initial Phase 1/2 clinical trial, which began in May.